Long-term outcome of targeted therapy of underlying conditions in patients with early persistent atrial fibrillation and heart failure: data of the RACE 3 trial.
Nguyen BO, Crijns HJGM, Tijssen JGP, Geelhoed B, Hobbelt AH, Hemels MEW, Mol WJM, Weijs B, Alings M, Smit MD, Tieleman RG, Tukkie R, Van Veldhuisen DJ, Van Gelder IC, Rienstra M; RACE 3 Investigators.
Nguyen BO, et al. Among authors: hemels mew.
Europace. 2022 Jul 15;24(6):910-920. doi: 10.1093/europace/euab270.
Europace. 2022.
PMID: 34791160
Free PMC article.
Clinical Trial.